References
- Clinical and Laboratory Standards Institute (CLSI). 2012. Reference method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne (PA): National Committee for Clinical Laboratory Standards.
- Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Lappin-Scott HM. 1995. Microbial biofilms. Annu Rev Microbiol. 49:711–745.
- Defraine V, Fauvart M, Michiels J. 2018. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics. Drug Resist Updat. 38:12–26.
- Gibbons S, Ohlendorf B, Johnsen I. 2002. The genus Hypericum-a valuable resource of anti-Staphylococcal leads. Fitoterapia. 73(4):300–304.
- Gu H, Lee SW, Carnicelli J, Zhang T, Ren D. 2020. Magnetically driven active topography for long-term biofilm control. Nat Commun. 11(1). .
- Jindal AK, Pandya K, Khan ID. 2015. Antimicrobial resistance: A public health challenge. Med J Armed Forces India. 71(2):178–181.
- Karaolis DKR, Rashid MH, Chythanya R, Luo W, Hyodo M, Hayakawa Y. 2005. c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation. Antimicrob Agents Chemother. 49(3):1029–1038.
- Lista do Brasil - Hypericum mutilum L. http://floradobrasil.jbrj.gov.br/jabot/FichaPublicaTaxonUC/FichaPublicaTaxonUC.do?id=FB8004 [accessed 2020 Mar 30].
- Lowy FD. 2003. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest. 111(9):1265–1273.
- Mittal N, Tesfu HH, Hogan AM, Cardona ST, Sorensen JL. 2019. Synthesis and antibiotic activity of novel acylated phloroglucinol compounds against methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo)). 72(5):253–259.
- Mukherjee PK, Saritha GS, Suresh B. 2001. Antibacterial spectrum of Hypericum hookerianum. Fitoterapia. 72(5):558–560.
- Rabanal RM, Arias A, Prado B, Hernández-Pérez M, Sánchez-Mateo CC. 2002. Antimicrobial studies on three species of Hypericum from the Canary Islands. J Ethnopharmacol. 81(2):287–292.
- Rice LB. 2009. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol. 12(5):476–481.
- Rocha L, Marston A, Potterat O, Kaplan MA, Stoeckli-Evans H, Hostettmann K. 1995. Antibacterial phloroglucinols and flavonoids from Hypericum brasiliense. Phytochemistry. 40(5):1447–1452.
- Rocha L, Marston A, Potterat O, Kaplan MAC, Hostettmann K. 1996. More phloroglucinols from Hypericum brasiliense. Phytochemistry. 42(1):185–188.
- WHO | Global action plan on AMR. 2020. WHO [Internet]. http://www.who.int/antimicrobial-resistance/global-action-plan/en/.[accessed 2020 Mar 30].
- Windels EM, Michiels JE, Fauvart M, Wenseleers T, Van den Bergh B, Michiels J. 2019. Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. ISME J. 13(5):1239–1251.